Efficacy of topiramate as add-on therapy in two different types of progressive myoclonic epilepsy.

Basit Öğe Kaydı
dc.contributor.authorDemir, Caner Feyzi
dc.contributor.authorOzdemir, Hasan Hüseyin
dc.contributor.authorMüngen, Bülent
dc.date.accessioned2026-08-12T16:11:30Z
dc.date.issued2013
dc.departmentFırat Üniversitesi
dc.description.abstractThe present article describes two unrelated cases of progressive myoclonic epilepsy (PME) of the Lafora's disease and Unverricht-Lundborg types who were treated with topiramate (TPM) as add-on therapy for their myoclonus. After the initiation of topiramate therapy both cases responded with marked decrease in myoclonic seizure frequency and improvement of quality of life. Topiramate appears to be a useful alternative agent in cases of PME and could be consider for adjunctive therapy.
dc.identifier.doi10.14712/18059694.2014.37
dc.identifier.endpage38
dc.identifier.issn1211-4286
dc.identifier.issue1
dc.identifier.pmid23909054
dc.identifier.scopus2-s2.0-84900780340
dc.identifier.scopusqualityQ3
dc.identifier.startpage36
dc.identifier.urihttps://doi.org/10.14712/18059694.2014.37
dc.identifier.urihttps://hdl.handle.net/11508/42514
dc.identifier.volume56
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.relation.ispartofActa medica (Hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20260511
dc.subjectAnticonvulsants; Drug Therapy, Combination; Female; Fructose; Humans; Myoclonic Epilepsies, Progressive; Young Adult; anticonvulsive agent; drug derivative; fructose; topiramate; article; case report; drug combination; female; human; myoclonus epilepsy; young adult
dc.titleEfficacy of topiramate as add-on therapy in two different types of progressive myoclonic epilepsy.
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu